Stemtech (STEK) Other Non-Current Assets (2021 - 2025)
Stemtech's (STEK) quarterly Other Non-Current Assets came in at $16480.0 in Q1 2025, down 29.58% year-on-year from $23404.0 in Q1 2024, and down 10.46% quarter-over-quarter from $18405.0 in Q2 2024.
Stemtech (STEK) Other Non-Current Assets (2021 - 2025) Analysis & Trends
Stemtech has disclosed Other Non-Current Assets across 5 years of filings, most recently posting $16480.0 for Q1 2025.
- Other Non-Current Assets for Q1 2025 came in at $16480.0, down 29.58% year-over-year; the trailing twelve-month figure through Mar 2025 was $16480.0 (down 29.58% YoY), and the FY2022 annual result was $23065.0, down 40.39% from the prior year.
- Other Non-Current Assets came in at $16480.0 for Q1 2025 at Stemtech, down from $18405.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $44043.0 in Q3 2021 to a low of $16480.0 in Q1 2025.
- The 5-year median for Other Non-Current Assets is $23634.0 (2023), against an average of $26889.9.
- Across the five-year window, Other Non-Current Assets slumped 40.39% in 2022 and fell 0.05% in 2024, its largest moves.
- Stemtech's Other Non-Current Assets stood at $38692.0 in 2021, then sank by 40.39% to $23065.0 in 2022, then rose by 2.29% to $23593.0 in 2023, then decreased by 21.99% to $18405.0 in 2024, then declined by 10.46% to $16480.0 in 2025.
- The last three Other Non-Current Assets figures came in at $16480.0 (Q1 2025), $18405.0 (Q2 2024), and $23404.0 (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Stemtech | - | - | 354,677.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 16,480.00 |
| Jun 30, 2024 | 18,405.00 |
| Mar 31, 2024 | 23,404.00 |
| Sep 30, 2023 | 23,593.00 |
| Jun 30, 2023 | 23,675.00 |
| Mar 31, 2023 | 23,416.00 |
| Dec 31, 2022 | 23,065.00 |
| Sep 30, 2022 | 28,416.00 |
| Jun 30, 2022 | 29,027.00 |
| Mar 31, 2022 | 30,463.00 |
| Dec 31, 2021 | 38,692.00 |
| Sep 30, 2021 | 44,043.00 |